Trial Details
TERMINATEDBasic Information
| Clinical ID | c1219 |
|---|---|
| Identifier | NCT04626947 |
| Trial Title | Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD). |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Ulcerative Colitis|Crohn Disease|C. Diff. Infections |
| Interventions | BIOLOGICAL: Bezlotoxumab |
Participant Information
| Sponsor | David Binion, MD |
|---|---|
| City | Pittsburgh |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2021-10-30 |
|---|---|
| Primary Completion Date | 2024-04-24 |
| Completion Date | 2024-05-31 |